Latest News - Boston Scientific
Top Corporates Hub
Boston Scientific
Boston Scientific (NYSE:BSX) Screens as a Decent Value with Strong Fundamentals
12.08.2026 11:52
Boston Scientific (BSX) screens as a decent value: cheap vs peers, strong profitability, and solid health, scoring 7/10.
Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players
11.08.2026 09:05
Pulsed Field Ablation Market Pulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast till 2035" has been added to ResearchAndMarkets.com's offering. The global pulsed field ablation market is projected to expand from approximately USD 3.2 billion in 2026 to USD 14.6 billion by 2035, re
Artisan Global Equity Fund Q2 2026 Portfolio Review
11.08.2026 05:10
The portfolio underperformed the MSCI All Country World Index during Q2. Read more here.
Artisan Global Equity Fund Q2 2026 Portfolio Review
11.08.2026 05:10
The portfolio underperformed the MSCI All Country World Index during Q2. Read more here.
Boston Scientific: The $5.4 Billion Quarter Tells Me The Sell-Off Is Overdone
11.08.2026 01:20
Despite U.S. growth headwinds for WATCHMAN and electrophysiology, Boston Scientific delivered strong Q2 2026 results. Read why BSX stock is a Strong Buy.
Boston Scientific Director Habiger Buys $100k of Shares Amid 54% Decline. What Does This Mean for BSX in 2026?
10.08.2026 18:14
Habiger's $100,000 purchase expanded his direct holdings by 14%, signaling confidence despite the stock's recent weakness. The acquisition came as shares traded near their lowest levels in over a year.
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?
10.08.2026 17:46
Mahoney expanded his equity stake by 13% following a -54% one-year stock decline. His combined holdings now total ~1.6 million shares valued at $78.08 million.
Boston Scientific (BSX) Q2 2026 Earnings Call Transcript
08.08.2026 00:14
WATCHMAN and Electrophysiology headwinds force guidance cut despite solid organic growth.
2 Profitable Stocks to Keep an Eye On and 1 We Turn Down
04.08.2026 12:13
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
BSX Q2 Earnings Call Highlights WATCHMAN and EP Pressure
30.07.2026 14:00
BSX faces WATCHMAN and EP pressures as management cuts outlook while highlighting cost savings and new product catalysts for future growth.
Truist Securities Maintains Buy on Boston Scientific, Lowers Price Target to $57
30.07.2026 11:08
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $62 to $57.
Evercore ISI Group Maintains Outperform on Boston Scientific, Lowers Price Target to $55
30.07.2026 10:21
Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $65 to $55.
Boston Scientific: Attempting The 2027 Reset
30.07.2026 10:01
Boston Scientific has reset expectations, slashing guidance and acknowledging competitive pressures. Find out why BSX stock is a buy.
Wells Fargo Maintains Equal-Weight on Boston Scientific, Lowers Price Target to $50
30.07.2026 09:56
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight and lowers the price target from $55 to $50.
Boston Scientific (BSX) Stock Sees Modest Fair Value Cut As Watchman Concerns Reset Expectations
30.07.2026 09:08
Analyst fair value for Boston Scientific has shifted from US$75.00 to US$72.25, pointing to a modest reset in price targets. This change lines up with recent research that lowers expectations for Watchman and electrophysiology while still recognizing strengths across the broader portfolio and generally positive ratings. As you read on, you will see how these moving targets, both bullish and bearish, shape the evolving Boston Scientific story and what to watch next. Stay updated as the Fair...
Boston Scientific (BSX) Is Up 7.1% After Q2 Beat, Recall And Major Restructuring Plan - Has The Bull Case Changed?
30.07.2026 04:28
Boston Scientific recently reported its second-quarter 2026 results, showing sales of US$5,442 million and net income of US$907 million, alongside issuing a recall of its Rapid Refill Continuous Injection System and initiating a multi-year global restructuring plan aimed at cost efficiencies. While the company raised full-year 2026 net sales growth expectations to approximately 5.5%–6.5%, it also outlined a restructuring program costing up to US$800 million and targeting around US$500...
Boston Scientific expects headcount reductions amid restructuring initiative
28.07.2026 16:34
Boston expects its restructuring plan to cost between $700m and $800m and be completed by the end of 2029.
Boston Scientific to restructure, taking up to $800M in charges
28.07.2026 10:53
The plan involves transferring production lines and cutting jobs, following a slowdown in two of the company’s key product lines.